Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Salivary Gland Neoplasms | 1 | 2023 | 13 | 0.870 |
Why?
|
Thyroid Neoplasms | 1 | 2023 | 33 | 0.840 |
Why?
|
Nitrosamines | 3 | 2022 | 11 | 0.830 |
Why?
|
Cytodiagnosis | 1 | 2020 | 15 | 0.730 |
Why?
|
Bile Ducts | 1 | 2020 | 20 | 0.720 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 32 | 0.720 |
Why?
|
Bile Duct Neoplasms | 1 | 2020 | 32 | 0.720 |
Why?
|
Adenocarcinoma | 1 | 2023 | 308 | 0.710 |
Why?
|
Pancreatic Cyst | 1 | 2019 | 4 | 0.690 |
Why?
|
Pancreas | 1 | 2019 | 103 | 0.650 |
Why?
|
Lung Neoplasms | 3 | 2022 | 412 | 0.620 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 31 | 0.610 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 134 | 0.610 |
Why?
|
Coccidioidomycosis | 1 | 2016 | 4 | 0.540 |
Why?
|
Lymph Nodes | 1 | 2016 | 107 | 0.500 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2014 | 2 | 0.490 |
Why?
|
Hepatitis | 1 | 2011 | 8 | 0.390 |
Why?
|
Fatty Liver | 1 | 2011 | 66 | 0.370 |
Why?
|
Humans | 16 | 2023 | 32005 | 0.290 |
Why?
|
Melanocytes | 1 | 2006 | 8 | 0.270 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2006 | 11 | 0.270 |
Why?
|
Child | 4 | 2020 | 2438 | 0.270 |
Why?
|
Diabetes Mellitus | 3 | 2019 | 411 | 0.240 |
Why?
|
Male | 9 | 2020 | 19165 | 0.240 |
Why?
|
Candida | 2 | 1995 | 7 | 0.230 |
Why?
|
Middle Aged | 6 | 2020 | 11817 | 0.230 |
Why?
|
Salivary Glands, Minor | 1 | 2023 | 10 | 0.220 |
Why?
|
Tongue | 1 | 2023 | 13 | 0.220 |
Why?
|
Skin Neoplasms | 1 | 2006 | 214 | 0.220 |
Why?
|
Young Adult | 2 | 2020 | 2636 | 0.210 |
Why?
|
Candidiasis, Oral | 3 | 1995 | 10 | 0.210 |
Why?
|
Carcinogens | 3 | 2022 | 35 | 0.210 |
Why?
|
Adult | 6 | 2020 | 9345 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 1328 | 0.190 |
Why?
|
Cholangitis, Sclerosing | 1 | 2020 | 6 | 0.180 |
Why?
|
Adolescent | 3 | 2020 | 3539 | 0.180 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2020 | 7 | 0.180 |
Why?
|
Cholangiocarcinoma | 1 | 2020 | 11 | 0.180 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 46 | 0.180 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 1992 | 251 | 0.180 |
Why?
|
Aged, 80 and over | 2 | 2020 | 3990 | 0.180 |
Why?
|
Cystic Fibrosis | 1 | 2019 | 23 | 0.170 |
Why?
|
Biopsy | 1 | 2020 | 259 | 0.170 |
Why?
|
Female | 7 | 2020 | 19959 | 0.160 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 582 | 0.160 |
Why?
|
Epithelial Cells | 1 | 2019 | 141 | 0.160 |
Why?
|
Needles | 1 | 2018 | 31 | 0.160 |
Why?
|
Diabetes Complications | 1 | 2019 | 177 | 0.150 |
Why?
|
Mouth | 2 | 1995 | 25 | 0.140 |
Why?
|
Ear Neoplasms | 1 | 2017 | 1 | 0.140 |
Why?
|
Carcinoid Tumor | 1 | 2017 | 13 | 0.140 |
Why?
|
Aged | 4 | 2020 | 10301 | 0.140 |
Why?
|
Coccidioides | 1 | 2016 | 2 | 0.130 |
Why?
|
Arizona | 1 | 2016 | 8 | 0.130 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 53 | 0.130 |
Why?
|
Rhodotorula | 1 | 1995 | 1 | 0.130 |
Why?
|
Paranasal Sinuses | 1 | 2014 | 4 | 0.120 |
Why?
|
Saccharomyces cerevisiae | 1 | 1995 | 20 | 0.120 |
Why?
|
Nose Neoplasms | 1 | 2014 | 4 | 0.120 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 6 | 0.120 |
Why?
|
Blood Group Antigens | 2 | 1992 | 4 | 0.120 |
Why?
|
Microscopy, Electron | 1 | 2014 | 30 | 0.120 |
Why?
|
Immunophenotyping | 1 | 2014 | 50 | 0.120 |
Why?
|
beta Catenin | 1 | 2014 | 37 | 0.120 |
Why?
|
Immunohistochemistry | 3 | 2017 | 538 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 367 | 0.110 |
Why?
|
Carrier State | 2 | 1992 | 23 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 1992 | 1428 | 0.110 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 163 | 0.110 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 517 | 0.110 |
Why?
|
Mutation | 1 | 2014 | 489 | 0.100 |
Why?
|
Retrospective Studies | 1 | 2020 | 3509 | 0.100 |
Why?
|
Tobacco | 1 | 2022 | 57 | 0.100 |
Why?
|
Phosphorylation | 1 | 2022 | 229 | 0.100 |
Why?
|
Smoking | 2 | 2022 | 497 | 0.100 |
Why?
|
Stomatitis, Denture | 1 | 1991 | 2 | 0.100 |
Why?
|
Lung | 2 | 2022 | 249 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 918 | 0.080 |
Why?
|
Mice | 2 | 2022 | 2484 | 0.070 |
Why?
|
S100 Proteins | 1 | 2006 | 18 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 45 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2006 | 148 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2005 | 135 | 0.060 |
Why?
|
Pyrones | 1 | 2022 | 4 | 0.050 |
Why?
|
DNA Adducts | 1 | 2022 | 12 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 19 | 0.050 |
Why?
|
Candida albicans | 2 | 1995 | 12 | 0.050 |
Why?
|
Dentures | 2 | 1992 | 5 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2022 | 48 | 0.050 |
Why?
|
DNA Damage | 1 | 2022 | 98 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2022 | 133 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2005 | 349 | 0.050 |
Why?
|
ABO Blood-Group System | 2 | 1991 | 19 | 0.050 |
Why?
|
Animals | 2 | 2022 | 7541 | 0.040 |
Why?
|
Age Factors | 2 | 1992 | 1188 | 0.040 |
Why?
|
Rats | 1 | 2022 | 1595 | 0.040 |
Why?
|
Ear Canal | 1 | 2017 | 4 | 0.040 |
Why?
|
Leukoplakia, Hairy | 1 | 1995 | 1 | 0.030 |
Why?
|
HIV Seronegativity | 1 | 1995 | 6 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2014 | 14 | 0.030 |
Why?
|
Betamethasone | 1 | 1995 | 53 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 263 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2014 | 108 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 1992 | 684 | 0.020 |
Why?
|
Chronic Disease | 1 | 1991 | 406 | 0.020 |
Why?
|
Sex Factors | 1 | 1991 | 663 | 0.020 |
Why?
|
Blood Glucose | 1 | 1991 | 494 | 0.020 |
Why?
|
Risk Factors | 1 | 1992 | 3876 | 0.010 |
Why?
|
Infant | 1 | 2005 | 1061 | 0.010 |
Why?
|
Child, Preschool | 1 | 2005 | 1269 | 0.010 |
Why?
|
Nystatin | 1 | 1995 | 2 | 0.010 |
Why?
|
Ketoconazole | 1 | 1995 | 5 | 0.010 |
Why?
|
Antifungal Agents | 1 | 1995 | 40 | 0.010 |
Why?
|
Asthma | 1 | 1995 | 259 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1989 | 57 | 0.010 |
Why?
|
Reference Values | 1 | 1989 | 246 | 0.010 |
Why?
|